Zebrafish Embryo Screening
Zebrafish Embryo Screening - Related Videos
04:22
Embryo-Based Chemical Toxicity Screen: Assessing Effects on Developing Zebrafish Embryos
0 Views •
2023
In this article, zebrafish embryos are used for chemical toxicity screening. Chemical toxicity is correlated with phenotype readouts. The sample protocol shows a methodological approach of performing the chemical toxicity screening.
07:48
Zebrafish Breeding and Embryo Handling
0 Views •
2023
Zebrafish (Danio rerio) are an important model organism that is particularly valuable for research in developmental biology. Zebrafish are extremely fertile and can produce hundreds of progeny per week, so it is relatively easy to collect a large number of embryos for high sample numbers. Furthermore, zebrafish undergo rapid development and embryos are transparent, allowing for easy visualization of developmental processes. This video covers the steps required for the collection of newly...
05:54
Microbead Implantation in the Zebrafish Embryo
0 Views •
Cited by 8 •
2015
The zebrafish is an excellent model system for genetic and developmental studies. Bead implantation is a valuable tissue manipulation technique that can be used to interrogate developmental mechanisms by introducing alterations in local cellular environments. This protocol describes how to perform microbead implantation in the zebrafish embryo.
05:41
Metabolic Profile Analysis of Zebrafish Embryos
0 Views •
Cited by 42 •
2013
Zebrafish represent a powerful vertebrate model that has been under-utilised for metabolic studies. Here we describe a rapid way to measure the in vivo metabolic profile of developing zebrafish that allows the comparison of different mitochondrial function parameters between genetically or pharmacologically manipulated embryos, thereby increasing the applicability of this organism.
07:03
Large Scale Zebrafish-Based In vivo Small Molecule Screen
0 Views •
Cited by 17 •
2010
Zebrafish has emerged as a powerful in vivo platform for phenotype-based drug screens and chemical genetic analysis. Here, we demonstrate a simple, practical method for large-scale screening of small molecules using zebrafish embryos.
FAQs
Rapid development allows researchers to observe biological changes within a relatively short investigation period, while transparency makes internal structures and organ formation visible without relying solely on invasive examination. Together, these features support direct monitoring of developmental outcomes and help screening platforms measure changes efficiently across many embryos or experimental conditions.
Conserved biological pathways provide a scientific basis for using zebrafish embryos to investigate processes relevant to other vertebrates. When a compound or altered genetic condition produces a measurable phenotype, the finding can help reveal a biological mechanism or developmental hazard that merits further evaluation in additional research models.
Screening can track survival, morphology, movement, organ formation, and other measurable phenotypes. These endpoints capture different forms of biological response: survival indicates severe effects, morphology and organ formation reveal developmental disruption, and movement provides information about functional changes. Examining several outcomes helps distinguish broad toxicity from more specific developmental or biological effects.
Compound exposure tests how an external chemical or candidate drug affects development, whereas altered genetic conditions help connect a phenotype to a biological change within the organism. Using both approaches can support complementary interpretation: chemicals may reveal hazards or pharmacological effects, while genetic conditions can help investigate mechanisms underlying observed developmental outcomes.
A typical workflow begins by placing developing embryos under a defined compound exposure or altered genetic condition. Researchers then monitor survival, morphology, movement, organ formation, or other measurable phenotypes as development proceeds. The resulting observations are evaluated to identify developmental hazards, biological effects, or promising responses that justify additional investigation.
In drug discovery, embryo screening can evaluate candidate drugs and help prioritize compounds for further testing. In environmental biology, it can assess chemicals and environmental contaminants for developmental effects. The same platform therefore supports both beneficial-use research, such as pharmacological investigation, and hazard-oriented studies focused on potential biological disruption.
Results can identify developmental hazards, suggest mechanisms associated with altered phenotypes, and rank compounds for follow-up work. In disease modeling, drug discovery, and environmental biology, this early evidence helps determine which conditions deserve more detailed study. The approach is especially useful for narrowing large sets of chemicals or candidates before later-stage investigation.